SCHEMBL25784855

SCHEMBL25784855

Cn1nccc1-c1cc2cc(C3CCCC3)cnc2[nH]1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 1/20 0.63
▸ CDK2 P24941 1/20 0.63
▸ COMT P21964 1/20 0.38
▸ PSMB5 P28074 1/20 0.38
▸ PDGFRB P09619 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ TBK1 Q9UHD2 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ INCENP Q9NQS7 1/20 0.36
▸ PLAT P00750 1/20 0.35
▸ ACVR1 Q04771 1/20 0.34
▸ BRD4 O60885 2/20 0.33
▸ BRD3 Q15059 1/20 0.33
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ HRH2 P25021 1/20 0.32
▸ HRH1 P35367 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25404996 0.88 CCNE1 (0.58) CCNE1CDK2COMTTBK1ABL1
SCHEMBL25781286 0.81 CDK2 (0.70) CCNE1CDK2COMTTBK1ABL1
SCHEMBL25784837 0.78 CDK2 (1.00) CCNE1CDK2
SCHEMBL25781281 0.78 CCNE1 (0.47) CCNE1CDK2COMTTBK1EGFR
SCHEMBL26320681 0.77 FAAH (0.43) CCNE1CDK2BRD4
SCHEMBL25781988 0.77 CDK2 (0.80) CCNE1CDK2
SCHEMBL25787378 0.75 CCNE1 (0.46) CCNE1CDK2COMTTBK1ABL1
SCHEMBL26320679 0.75 BRD4 (0.49) PSMB5BRD4
SCHEMBL25781276 0.72 RIPK1 (0.50) COMT
SCHEMBL25785187 0.72 PDGFRB (0.47) CCNE1CDK2PSMB5PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168686-A1 SUBSTITUTED CYCLOPENTANES AS CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2023-09-14 — — WO disclosed
WO-2023116884-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2023-06-29 — — WO disclosed
Send feedback